Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0007479
UniProt IDQ9Y490
Primary gene name(s)TLN1
Synonym gene name(s)KIAA1027, TLN
Protein nameTalin-1
Protein functionProbably involved in connections of major cytoskeletal structures to the plasma membrane. High molecular weight cytoskeletal protein concentrated at regions of cell-substratum contact and, in lymphocytes, at cell-cell contacts, By similarity. {ECO:0000250}.
Subcellular locationCell projection, ruffle membrane {ECO:0000250};
Peripheral membrane protein {ECO:0000250};
Cytoplasmic side {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Cell surface {ECO:0000250}. Cell junction, focal adhesion {ECO:0000250}. Note=Colocalizes with LAYN at the membrane ruffles. Localized preferentially in focal adhesions than fibrillar adhesions, By similarity. {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q9Y490
Gene Ontology
(Biological Process)
Complete annatation
cell-cell junction assembly [GO:0007043];
cell-substrate junction assembly [GO:0007044];
cortical actin cytoskeleton organization [GO:0030866];
cytoskeletal anchoring at plasma membrane [GO:0007016];
IRE1-mediated unfolded protein response [GO:0036498];
movement of cell or subcellular component [GO:0006928];
muscle contraction [GO:0006936];
platelet aggregation [GO:0070527];
platelet degranulation [GO:0002576];
viral process [GO:0016032]
Gene Ontology
(Molecular Function)
Complete annatation
integrin binding [GO:0005178];
LIM domain binding [GO:0030274];
structural constituent of cytoskeleton [GO:0005200];
vinculin binding [GO:0017166]
Gene Ontology
(Cellular Component)
Complete annatation
cell-cell junction [GO:0005911];
cell surface [GO:0009986];
cytoplasm [GO:0005737];
cytosol [GO:0005829];
extracellular exosome [GO:0070062];
extracellular region [GO:0005576];
focal adhesion [GO:0005925];
microtubule organizing center [GO:0005815];
plasma membrane [GO:0005886];
ruffle [GO:0001726];
ruffle membrane [GO:0032587]
Protein-protein interaction112949
Phylogenetic treeQ9Y490
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.395168912690870.2273834986928450.337016824889227
AZA vs. DISU0.01116931893038840.9646757425255220.996672625553768
AZA vs. IL70.107897157511620.57348664125950.999311006273513
AZA vs. SAHA-0.1008688344201980.6784663228412320.90621672242426
DISU vs. CD30.3944368274221930.2763962554429290.405409862269798
DISU vs. IL70.08710924593193950.7290997452738910.932166793317268
DISU vs. SAHA-0.1094723970103810.7066392935163370.912981856919095
DMSO vs. AZA0.07991130317037220.6317457715422851
DMSO vs. CD30.4650653839356330.1466889239257380.23278928041096
DMSO vs. DISU0.06731432690569940.7821528199032190.972448065006312
DMSO vs. IL70.03514573976179480.844367039176990.965893808682174
DMSO vs. SAHA-0.1864862643794160.4276271182544620.764503950084579
HIV vs. Mock in Activation0.3470663746532610.5767681182320760.999983755607037
HIV vs. Mock in Latency0.1376756306813530.4027583800916180.999834320637052
IL7 vs. CD30.5085845564004750.1147828138791210.21083613863027
SAHA vs. CD30.2712312786857650.4428726239427120.555664844127606
SAHA vs. IL7-0.2109296454919670.3852318586430430.634851321437108
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.106635 0.563841
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.994 0.951 1.073 1.167 1.077
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1SYQ X-ray 2.4Å B=607-631.
2MWN NMR - B=308-400.
4DJ9 X-ray 2.2Å B=2075-2103.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
retropepsin cleaves 12119179
matrix interacts with 22017400

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa04015 Rap1 signaling pathway - Homo sapiens (human)
hsa04510 Focal adhesion - Homo sapiens (human)
hsa04611 Platelet activation - Homo sapiens (human)
hsa05166 HTLV-I infection - Homo sapiens (human)